Hepatocellular transport and gastrointestinal absorption of lanthanum in chronic renal failure (Q46217195)

20 December 2017

title

Hepatocellular transport and gastrointestinal absorption of lanthanum in chronic renal failure (English)

1 reference

20 December 2017

10

Ronny Blust

1 reference

20 December 2017

7

Stephen J P Damment

1 reference

20 December 2017

Geert J Behets

2

object named as

Geert J Behets

1 reference

20 December 2017

Marc E. De Broe

11

object named as

Marc E De Broe

1 reference

20 December 2017

Patrick C D'Haese

12

object named as

Patrick C D'Haese

1 reference

20 December 2017

author name string

An R J Bervoets

1

1 reference

20 December 2017

Dominick Schryvers

3

1 reference

20 December 2017

Frank Roels

4

1 reference

20 December 2017

Zhang Yang

5

1 reference

20 December 2017

Steven C Verberckmoes

6

1 reference

20 December 2017

Simonne Dauwe

8

1 reference

20 December 2017

Valentine K Mubiana

9

1 reference

20 December 2017

language of work or name

English

0 references

publication date

3 December 2008

1 reference

20 December 2017

published in

Kidney International

1 reference

20 December 2017

volume

75

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

389-398

1 reference

20 December 2017

Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD).

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Cardiovascular calcification in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Gastrointestinal absorption of aluminum from aluminum-containing antacids

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Assessment of effects of lanthanum carbonate with and without phosphate supplementation on bone mineralization in uremic rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Absolute bioavailability and disposition of lanthanum in healthy human subjects administered lanthanum carbonate.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Progressive accumulation of lanthanum in the liver of normal and uremic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

The need for contamination control in studies on lanthanum biodisposition

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Incredulous effects of lanthanum?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Lanthanum: a safe phosphate binder

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Paracellular pathway in the shell epithelium of Anodonta cygnea

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Liver microsomes; an integrated morphological and biochemical study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Demonstration of lanthanum in liver cells by energy-dispersive X-ray spectroscopy, electron energy loss spectroscopy and high-resolution transmission electron microscopy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Systemic lanthanum is excreted in the bile of rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Biliary copper excretion by hepatocyte lysosomes in the rat. Major excretory pathway in experimental copper overload

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Alterations in the structure, physicochemical properties, and pH of hepatocyte lysosomes in experimental iron overload

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Early effects of gentamicin, tobramycin, and amikacin on the human kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Enlightenment on liver lanthanum exposure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Increased intestinal permeability to differently sized polyethylene glycols in uremic rats: effects of low- and high-protein diets

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Enhanced gastrointestinal absorption of aluminum in uremic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Lanthanum pharmacokinetics: are rat data misleading?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

The need for careful interpretation of animal data on lanthanum

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Cognitive function in Stage 5 chronic kidney disease patients on hemodialysis: no adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Development and reversibility of impaired mineralization associated with lanthanum carbonate treatment in chronic renal failure rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Human liver pathology in peroxisomal diseases: a review including novel data

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.571

7 January 2021

Identifiers

DOI

10.1038/KI.2008.571

1 reference

20 December 2017

1 reference

20 December 2017